Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of securities of Jayud Global Logistics Ltd. for the period between April 21, 2023, and April 30, 2025, due to alleged misleading statements and fraudulent activities [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Jayud was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [5]. - It is alleged that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign, which was not disclosed in Jayud's public statements [5]. - The lawsuit asserts that Jayud's positive statements about its business and operations were materially misleading and lacked a reasonable basis due to the undisclosed fraudulent activities [5]. Group 2: Participation Information - Investors who purchased Jayud securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must move the Court by January 20, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking high in settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4].

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TLXNovember 28, 2025 5:26 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 28, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both da ...

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - STUBNovember 28, 2025 3:01 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 28, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or traceable to the Registration State ...

Core Insights - Rosen Law Firm is investigating potential securities claims on behalf of Hormel Foods Corporation investors due to allegations of misleading business information [2] - Hormel Foods recently cut its earnings forecast, citing price pressures, bird flu, and a fire at its Arkansas peanut butter production facility, leading to a 9.1% drop in stock price [4] Group 1: Legal Investigation - The investigation is focused on whether Hormel Foods issued materially misleading information to the public [2] - Investors who purchased Hormel securities may be entitled to compensation through a class action without upfront costs [3] Group 2: Company Performance - Hormel Foods warned that its earnings were negatively impacted in the latest quarter due to various pressures, including price increases and operational disruptions [4] - The company announced a leadership change, parting ways with its Chief Financial Officer amid these challenges [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Western Alliance Bancorporation due to allegations of materially misleading business information [2][3] Group 1: Legal Action and Stock Impact - Western Alliance Bancorporation initiated a lawsuit against Cantor Group V LLC for fraud related to collateral loans, resulting in a 10.88% stock price drop on October 16, 2025 [4] Group 2: Class Action Information - Investors who purchased Western Alliance Bancorporation securities may be entitled to compensation through a class action without any out-of-pocket fees, with Rosen Law Firm preparing to seek recovery of investor losses [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognized as a leading firm in the field, recovering hundreds of millions for investors [5]

Core Viewpoint - Rosen Law Firm is encouraging investors of Avantor, Inc. to secure legal counsel before the December 29, 2025 deadline for a class action lawsuit related to the company's stock performance during the specified class period [1][2]. Group 1: Class Action Details - The class action pertains to investors who purchased Avantor common stock between March 5, 2024, and October 28, 2025, and they may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][5]. - Investors wishing to serve as lead plaintiffs must file a motion with the court by December 29, 2025, to represent other class members in the litigation [3][7]. Group 2: Allegations Against Avantor - The lawsuit alleges that Avantor misrepresented its competitive positioning, which was weaker than publicly stated, and that the company was negatively impacted by increased competition [5]. - It is claimed that the defendants' representations regarding Avantor's business operations and prospects were materially false and misleading, leading to investor damages when the true information became public [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Skye Bioscience, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Skye Bioscience securities is from November 4, 2024, to October 3, 2025, inclusive [1]. - Investors who purchased Skye securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 16, 2026 [2]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions [3]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [3]. - The firm has been consistently ranked among the top firms for securities class action settlements since 2013 [3]. Group 3: Case Allegations - The lawsuit alleges that during the Class Period, defendants made materially false and misleading statements regarding Skye's business and the effectiveness of its product, nimacimab [4]. - Specifically, it is claimed that nimacimab was less effective than represented, leading to overstated clinical, regulatory, and commercial prospects [4]. - The lawsuit asserts that when the true information became public, investors suffered damages as a result [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of America's Car-Mart, Inc. due to allegations of materially misleading business information issued to the investing public [1]. Group 1: Legal Action and Compensation - Shareholders who purchased America's Car-Mart securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees or costs [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses [2]. Group 2: Company Performance and Stock Impact - On September 4, 2025, America's Car-Mart reported a first-quarter loss of 69 cents per share, compared to a net loss of 15 cents per share in the same period the previous year [3]. - Following the release of these results, America's Car-Mart's stock experienced a decline of 18.2% on the same day [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of investors in Jayud Global Logistics Ltd. for securities purchased between April 21, 2023, and April 30, 2025, highlighting the importance of securing counsel before the January 20, 2026 deadline for lead plaintiff applications [1][3]. Group 1: Class Action Details - The class action lawsuit has already been filed, and investors who purchased Jayud securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][5]. - Investors interested in joining the class action can do so by visiting the provided link or contacting the law firm directly [3][6]. Group 2: Allegations Against Jayud - The lawsuit alleges that during the Class Period, Jayud made materially false and misleading statements and failed to disclose critical information, including involvement in a fraudulent stock promotion scheme and the use of offshore accounts for share dumping [5]. - The claims suggest that Jayud's public statements regarding its business and operations were misleading and lacked a reasonable basis due to the undisclosed risks and artificial trading activities affecting the stock price [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm is recognized for its expertise in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Inspire Medical Systems, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on January 5, 2026 [1]. Group 1: Class Action Details - Investors who bought Inspire Medical common stock between August 6, 2024, and August 4, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by January 5, 2026 [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in this area [4]. - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Background - The lawsuit alleges that Inspire Medical misrepresented key facts about its sleep apnea device, Inspire V, including market demand and readiness for launch, leading to investor losses when the truth was revealed [5].